STEPHEN ROCAMBOLI
CIK 1221451 · Secretary · last filed 2025-06-02
STEPHEN ROCAMBOLI is a Secretary who has filed 21 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for ESPR, was dated Jun 2, 2025. Across all open-market trades the lifetime net is −$865.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $218.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$218.2K
2
21
-$865.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESPR | Director | 69,261 | $3.15 | $218.2K | $12.1K | 5 | 2025-06-02 |
| TFF Pharmaceuticals, Inc. (TFFP) Delisted | Director | 39,165 | $0.07 | $2.5K | -$877.9K | 12 | 2024-07-08 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-02 | ESPR | Grant (A) | +33,000 | $0 | EDGAR |
| 2024-07-08 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | +3,165 | $0 | EDGAR |
| 2024-05-24 | ESPR | Grant (A) | +23,000 | $0 | EDGAR |
| 2024-04-22 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-12-04 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-15 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +20,000 | $5.0K | EDGAR |
| 2023-06-16 | ESPR | Grant (A) | +5,150 | $0 | EDGAR |
| 2023-05-11 | ESPR | Buy (P) | +8,111 | $12.1K | EDGAR |
| 2023-03-13 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +13,000 | $10.4K | EDGAR |
| 2022-12-30 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |